Table 1. Clinical and pathological characteristics of patients included in the present study.
| Characteristics | Screening set (n=30) | Validation set (n=54) | FFPE set (n=115) | Urine set (n=104) |
|---|---|---|---|---|
| Age, years | ||||
| Mean ± SD | 63.62±12.73 | 62.28±11.35 | 60.81±11.47 | 63.99±10.15 |
| Median [range] | 66.0 [34–78] | 64.5 [33–84] | 62.0 [32–82] | 64.0 [30–84] |
| Sex | ||||
| Male | 18 (60.0) | 47 (87.04) | 90 (78.3) | 85 (81.7) |
| Female | 12 (40.0) | 7 (12.96) | 25 (21.7) | 19 (19.3) |
| Alcohol consumption | ||||
| Yes | 7 (23.3) | 12 (22.2) | 14 (12.2) | 20 (23.8) |
| No | 23 (76.7) | 42 (77.8) | 101 (87.8) | 84 (76.1) |
| Smoking history | ||||
| Yes | 10 (33.3) | 22 (40.7) | 58 (50.4) | 41 (39.4) |
| No | 20 (66.7) | 32 (59.3) | 57 (49.6) | 63 (60.6) |
| Tumor stage | ||||
| Non-invasive | 16 (50.0) | 32 (59.26) | 59 (51.3) | 81 (77.9) |
| Ta | 2 | 6 | 5 | 30 |
| T1 | 14 | 26 | 54 | 51 |
| Invasive | 14 (50.0) | 22 (40.74) | 56 (48.7) | 23 (22.1) |
| T2 | 11 | 12 | 37 | 13 |
| T3 | 3 | 9 | 16 | 9 |
| T4 | 0 | 1 | 3 | 1 |
| Tumor grade | ||||
| Low | 12 (40.0) | 20 (37.0) | 43 (37.4) | 57 (54.8) |
| High | 18 (60.0) | 34 (63.0) | 72 (62.6) | 47 (45.2) |
| Multifocality | ||||
| Yes | 18 (60.0) | 33 (61.1) | 43 (37.4) | 47 (45.2) |
| No | 12 (40.0) | 21 (38.9) | 72 (62.6) | 57 (54.8) |
FFPE, formalin-fixed, paraffin-embedded; SD, standard deviation.